Cytarabine/daunorubicin

Liposomal daunorubicin/Cytarabine is a fixed-dose combination of liposomal bound cytarabine and daunorubicin that delivers the two medications in a 5:1 molar ratio. Liposomal daunorubicin/Cytarabine is a fixed-dose combination of liposomal bound cytarabine and daunorubicin that delivers the two medications in a 5:1 molar ratio. It is used in the treatment of acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).